advertisement
Prokosch-Willing V 15
Showing records 1 to 15 | Display all abstracts from Prokosch-Willing V100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Thein AS
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Gietzelt C; Lüke JN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Hedengran A; Azuara-Blanco A
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Adler W
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Arita R
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Dietlein TS; Lappas A
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Cvenkel B
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Prokosch-Willing V
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Gazzard G; Heegaard S
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Roters S
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
de Paiva CS
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Heindl LM; Cursiefen C
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Petrovski G
American Journal of Ophthalmology 2022; 241: 190-197
100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Enders P
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Prokosch-Willing V; Utheim TP; Virgili G; Kolko M
American Journal of Ophthalmology 2022; 241: 190-197